STXS
Stereotaxis Inc
Halal Rating :
Last Price
$2.09
Last updated:
Market Cap
-
7D Change
0.48%
1 Year Change
5.56%
Company Overview
Industries
Exchange
Next Earnings Date
Stereotaxis is a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention. The company develops robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Their primary products include the Genesis RMN System, which enables physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $9.2m | $15.39m | - | $-150000.0 | 0.00% | 0.97% |
| June 30, 2024 | $4.5m | $10.33m | - | $-191000.0 | 0.00% | 1.85% |
| March 31, 2024 | $6.88m | $11.39m | - | $-239000.0 | 0.00% | 2.10% |
Company Impact
Help us evaluate Stereotaxis Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.